Breadcrumb Home Read, watch, listen Read Explore what's trending at Prime Example Link Example Link Card Title example Example Link Example Link Card Title example The Latest Tab 1 Press Releases...

Managed Healthcare Executive

Endpoint News

USA Today

Reuters

Insider

CNBC

Formulary Watch

Star Tribune

Business Insider

Reuters

NBC News: Patients weren't asked why they quit taking the weight loss drugs

Reuters

Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.

Reuters

Reuters

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

PUBLICATIONS FDA Decisions Expected: July 2025 Your monthly synopsis of new drugs expected to hit the market June 18, 2025 Drug pipeline for July 2025 At Prime Therapeutics (Prime), we have...

Perspectives High-Cost Therapy Profile: March Detailed information about Sotatercept Subcutaneous (SC) High Cost Therapy Profile Cardiovascular Sotatercept Subcutaneous (SC) Merck/Bristol-Myers...

Marquee event showcased new Prime, our energy, ambition and transformative journey

Drug Approvals Quarterly Update: April 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...

publications High-Cost Therapy Profile: June 2025 Zopapogene imadenovec Subcutaneous (SC) | Precigen, Inc. Infectious Disease June 18, 2025 Proposed indications Recurrent respiratory...

Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

research 8 research posters presented by Prime at the 2024 AMCP Annual Meeting Prime remains at the forefront of researching real-world drug utilization, managed care pharmacy programs, and costs...

AMCP Annual Meeting 2025 research posters Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model Click on the poster image to view the full-size version. Prime...

Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications Weight management: A holistic journey May 1, 2024 Obesity is a global epidemic and major public health issue that has grown in prevalence over recent decades in adults, adolescents...

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...

Event features discussions about health care industry trends, best practices and innovations

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Cover image for Drug Approvals Monthly Update: September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

Cover image for Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024